🇺🇸 FDA
Patent

US 9688722

Substrates and inhibitors of prolyl oligopeptidase and methods of use

granted A61KA61K38/00A61K38/1825

Quick answer

US patent 9688722 (Substrates and inhibitors of prolyl oligopeptidase and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/00, A61K38/1825, A61K38/1858, A61K38/21